E-LIB Suche - Ergebnisse für: Julku, Ulrika

1

A prolyl oligopeptidase inhibitor reduces tau pathology in ..:

Eteläinen, Tony S ; Silva, M.Catarina ; Uhari-Väänänen, Johanna K...
10.1126/scitranslmed.abq2915. , 2024

2

Prolyylioligopeptidaasin estäjistä apua muistisairauksien p..:

Eteläinen, Tony S ; Silva, M.Catarina ; Uhari-Väänänen, Johanna K...
Eteläinen , T S , Silva , M C , Uhari-Väänänen , J K , De Lorenzo , F , Jäntti , M H , Cui , H , Chavero-Pieres , M , Kilpeläinen , T , Mechtler , C , Svarcbahs , R , Seppälä , E , Savinainen , J R , Puris , E , Fricker , G , Gynther , M , Julku , U H , Huttunen , H J , Haggarty , S J & Myöhänen , T 2023 , ' Prolyylioligopeptidaasin estäjistä apua muistisairauksien pysäyttämiseen? ' , Duodecim , Vuosikerta. 139 , Nro 11 , Sivut 941 .. , 2024

Link: http://hdl.handle.net/10..

3

Novel Small‐Molecular Ligands for Prolyl Oligopeptidase to ..:

Eteläinen, Tony ; Pätsi, Henri ; Uhari‐Väänänen, Johanna...
Alzheimer's & Dementia. 19 (2023) S21 - p. , 2023

Link: https://doi.org/10.1002/..

4

Long-term effects of immunotherapy with a brain penetrating..:

Gustavsson, Tobias ; Metzendorf, Nicole G. ; Wik, Elin...
Alzheimer's Research & Therapy. 15 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

5

Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands wit..:

Kilpeläinen, Tommi P. ; Pätsi, Henri T. ; Svarcbahs, Reinis...
Journal of Medicinal Chemistry. 66 (2023) 11 - p. 7475-7496 , 2023

Link: https://doi.org/10.1021/..

6

Long-term effects of immunotherapy with a brain penetrating..:

Tobias Gustavsson ; Nicole G. Metzendorf ; Elin Wik...
https://doi.org/10.1186/s13195-023-01236-3. , 2023

Link: https://doi.org/10.1186/..

7

Long-term effects of immunotherapy with a brain penetrating..:

Gustavsson, Tobias ; Metzendorf, Nicole G ; Wik, Elin...
Alzheimer's Research & Therapy, 2023, 15:1,. , 2023

Link: http://urn.kb.se/resolve..

8

Removal of proteinase K resistant alpha Syn species does no..:

Eteläinen, Tony S ; Kilpeläinen, Tommi P ; Ignatius, Adele...
10.1016/j.neuropharm.2022.109213. , 2023

Link: http://hdl.handle.net/10..

9

Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands wit..:

Kilpelainen, Tommi P ; Patsi, Henri T ; Svarcbahs, Reinis...
10.1021/acs.jmedchem.3c00235. , 2023

Link: http://hdl.handle.net/10..

10

PET Imaging in Preclinical Anti-Aβ Drug Development:

Syvänen, Stina ; Meier, Silvio R. ; Roshanbin, Sahar...
Pharmaceutical Research. 39 (2022) 7 - p. 1481-1496 , 2022

Link: https://doi.org/10.1007/..

11

Brain pharmacokinetics of mono- and bispecific amyloid-β an..:

Julku, Ulrika ; Xiong, Mengfei ; Wik, Elin...
Fluids and Barriers of the CNS. 19 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

12

Reduction of αSYN Pathology in a Mouse Model of PD Using a ..:

Roshanbin, Sahar ; Julku, Ulrika ; Xiong, Mengfei...
Pharmaceutics. 14 (2022) 7 - p. 1412 , 2022

Link: https://doi.org/10.3390/..

13

Removal of proteinase K resistant αSyn species does not cor..:

Eteläinen, Tony S. ; Kilpeläinen, Tommi P. ; Ignatius, Adele...
Neuropharmacology. 218 (2022) - p. 109213 , 2022

Link: https://doi.org/10.1016/..

14

Reduction of αSYN Pathology in a Mouse Model of PD Using a ..:

Sahar Roshanbin ; Ulrika Julku ; Mengfei Xiong...
Drug Delivery and Controlled Release. , 2022

Link: https://doi.org/10.3390/..

15

Brain pharmacokinetics of mono- and bispecific amyloid-beta..:

Julku, Ulrika ; Xiong, Mengfei ; Wik, Elin...
Fluids and Barriers of the CNS, 2022, 19,. , 2022

Link: http://urn.kb.se/resolve..